AbCellera Biologics (ABCL) Change in Taxes (2021 - 2026)
AbCellera Biologics (ABCL) posted Change in Taxes of -$5.0 million for Q1 2026, up 50.55% on a QoQ basis from -$10.1 million in Q4 2025, and down 12.75% year-over-year from -$5.7 million in Q1 2025.
AbCellera Biologics (ABCL) Change in Taxes (2021 - 2026) Analysis & Trends
AbCellera Biologics' Change in Taxes history runs 6 years deep, the most recent figure standing at -$5.0 million for Q1 2026.
- Quarterly Change in Taxes fell 12.75% year-over-year to -$5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$30.4 million (down 660.46% YoY) and the FY2025 annual result came in at -$29.8 million, down 548.7% from the prior year.
- Change in Taxes was -$5.0 million for Q1 2026 at AbCellera Biologics, up from -$10.1 million in the prior quarter.
- Across five years, Change in Taxes topped out at $70.0 million in Q1 2022 and bottomed at -$87.2 million in Q3 2022.
- A 5-year average of -$5.1 million and a median of -$3.2 million in 2024 frame the typical range for Change in Taxes.
- Peak annual rise in Change in Taxes reached 1242.66% in 2022, while the deepest fall reached 11467.01% in 2022.
- AbCellera Biologics' Change in Taxes stood at -$53.7 million in 2022, then jumped by 103.31% to $1.8 million in 2023, then surged by 763.41% to $15.4 million in 2024, then sank by 165.44% to -$10.1 million in 2025, then jumped by 50.55% to -$5.0 million in 2026.
- Business Quant data shows ABCL's Change in Taxes at -$5.0 million in Q1 2026, -$10.1 million in Q4 2025, and -$12.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | AbCellera Biologics | 1.72 Bn | 1.72 Bn | - | -4.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.97 Mn |
| Mar 31, 2026 | -4.97 Mn |
| Dec 31, 2025 | -10.05 Mn |
| Dec 31, 2025 | -10.05 Mn |
| Sep 30, 2025 | -12.20 Mn |
| Sep 30, 2025 | -12.20 Mn |
| Jun 30, 2025 | -3.18 Mn |
| Jun 30, 2025 | -3.18 Mn |
| Mar 31, 2025 | -4.41 Mn |
| Mar 31, 2025 | -4.41 Mn |
| Dec 31, 2024 | 15.36 Mn |
| Dec 31, 2024 | 15.36 Mn |
| Sep 30, 2024 | -2.76 Mn |
| Sep 30, 2024 | -2.76 Mn |
| Jun 30, 2024 | -2.77 Mn |
| Jun 30, 2024 | -2.77 Mn |
| Mar 31, 2024 | -3.18 Mn |
| Mar 31, 2024 | -3.18 Mn |
| Dec 31, 2023 | 1.78 Mn |
| Dec 31, 2023 | 1.78 Mn |